Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,728 across all filing types
Latest filing 2014-11-12 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
七届二十八次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details the decisions made at the 28th meeting of the 7th board of directors, including approval of an investment increase for a project. The document includes voting results and confirms compliance with company law and articles of association. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is an announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, not a full report or regulatory filing.
2014-11-12 Chinese
关于终止收购资产事项的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement from Kunming Pharmaceutical Group Co., Ltd. regarding the termination of an asset acquisition transaction. It references a previous acquisition announcement and states that the company has decided to terminate the acquisition due to failure to reach agreement on terms. The document is brief (491 characters) and serves as a notification to investors about the termination of a planned acquisition. It does not contain detailed financial data, merger documents, or full reports. Therefore, it is best classified as a Capital/Financing Update (CAP) since it relates to a change in the company's financing or capital transaction plans (termination of an acquisition).
2014-11-11 Chinese
2014年第三季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2014 年第三季度报告' which translates to '2014 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2014. The document is comprehensive, with actual financial figures and analysis for the quarter ending September 30, 2014. It is explicitly stated as a quarterly report and includes unaudited financial statements. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. The document is not a brief announcement or a certification, but a full report with detailed financial statements and explanations. Therefore, the correct classification is IR with high confidence. 9M 2014
2014-10-21 Chinese
2014年第二次临时股东大会的法律意见书
Regulatory Filings Classification · 100% confidence The document contains only placeholders for images and no textual content or substantive information. It is extremely short (110 characters) and does not contain any report, announcement, or financial data. Given the lack of content, it cannot be classified as any specific report type and defaults to Regulatory Filings (RNS) as a fallback category.
2014-10-10 Chinese
七届二十六次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 26th meeting of the 7th Board of Directors of Kunming Pharmaceutical Group Co., Ltd. It includes specific investment decisions, authorization for land acquisition, and disposal of idle land. The content focuses on board decisions and approvals rather than financial results, audit opinions, or shareholder voting outcomes. There is no indication of it being a full annual or interim report, earnings release, or regulatory filing. The document is clearly a Board/Management Information announcement about board meeting resolutions and management authorizations.
2014-10-10 Chinese
2014年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2014 second extraordinary general meeting (临时股东大会) of Kunming Pharmaceutical Group Co., Ltd. It details the voting results on various proposals related to the issuance of domestic corporate bonds, including quantity, terms, interest rates, guarantees, use of funds, and authorization to the board. The document includes attendance details, voting percentages, and legal witness statements confirming the validity of the meeting and voting process. There is no detailed financial data or report content, only the official voting results and resolutions. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2408 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2014-10-10 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.